AEye Reports Third Quarter 2022 Results
AEye, Inc. (Nasdaq: LIDR) reported its third quarter results for 2022, revealing revenue of $0.8 million and a GAAP net loss of $(23.6) million or $(0.15) per share. Non-GAAP net loss stood at $(17.0) million or $(0.11) per share. AEye launched its 4Sight™ product line, designed for high-performance applications such as autonomous trucking and aerospace. The company is establishing a manufacturing line in Thailand with partners Sanmina and Continental, aiming for low-cost production. As of September 30, 2022, AEye had $112.2 million in cash and equivalents.
- Launch of the groundbreaking 4Sight™ product line tailored for high-performance applications.
- Expansion with new manufacturing capabilities in Thailand through partnerships with Sanmina and Continental.
- Presence of substantial cash reserves totaling $112.2 million, indicating financial stability.
- Significant GAAP net loss of $(23.6) million in Q3 2022.
- Revenue of only $0.8 million, indicating challenges in generating sales.
Third quarter revenue in line with expectations
Product launch, new markets expansion, and continued momentum with existing partners provide foundation for growth
“As planned, today we are excited to launch our 4Sight™ line of products which we believe to be built on the industry’s premier high performance adaptive lidar platform. The reaction we are getting from users who require high performance capabilities like autonomous hub-to-hub trucking, true high-speed highway autopilot, and other high-impact industrial, aerospace, and defense applications is incredibly encouraging. We believe the 4Sight platform is groundbreaking and will accelerate the adoption of lidar across diverse markets. The 4Sight platform differs from many other ‘point’ lidar solutions in that it is natively architected to integrate with other sensors and across networks to not only deliver optimal pre-perception data, but also help users customize how, when, and where they process critical information to make autonomous decisions,” said
“Today, we also are announcing that we have broken ground on our high-volume manufacturing line at Sanmina’s future plant in
Q3 2022 Financials
-
Revenue of
in the third quarter of 2022.$0.8 million -
GAAP net loss was
in the third quarter of 2022, or$(23.6) million per share based on 159.3 million weighted average common shares outstanding.$(0.15) -
Non-GAAP net loss was
in the third quarter of 2022, or$(17.0) million per share based on 159.3 million weighted average common shares outstanding.$(0.11) -
Cash, cash equivalents, and marketable securities were
as of$112.2 million September 30, 2022 . This excludes up to in available liquidity from our Common Stock Purchase Agreement with$122 million Tumim Stone Capital LLC .
Conference Call and Webcast Details
The webcast and accompanying slides will be accessible via the company’s website at https://investors.aeye.ai/.
The call is also accessible via telephone through the following details:
Dial in Information:
- Participant Toll-Free Dial-In Number: 844-763-8274
- Participant International Dial-In Number: 412-717-9224
About
AEye’s unique software-defined lidar solution enables advanced driver-assistance, vehicle autonomy, smart infrastructure, logistics and off-highway applications that save lives and propel the future of transportation and mobility. AEye’s 4Sight™ Intelligent Sensing Platform, with its adaptive sensor-based operating system, focuses on what matters most; delivering faster, more accurate, and reliable information. AEye’s 4Sight™ products, built on this platform, are ideal for dynamic applications which require precise measurement imaging to ensure safety and performance.
Non-GAAP Financial Measures
The non-GAAP measures provided in this press release should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with generally accepted accounting principles (GAAP) in
This presentation includes non-GAAP financial measures, including:
- Non-GAAP net loss which is defined as GAAP net loss plus stock-based compensation, plus expenses related to registrations on Form S-1/S-3, plus stock issuance costs, less change in fair value of embedded derivative and warrant liabilities, plus debt issuance costs, less the gain on PPP loan forgiveness; and
- Adjusted EBITDA which is defined as non-GAAP net loss plus amortization and depreciation expense, plus interest expense and other, less interest income and other, plus provision for income tax expense.
Forward-Looking Statements
Certain statements included in this press release that are not historical facts are forward-looking statements within the meaning of the federal securities laws, including the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements are sometimes accompanied by words such as “believe,” “continue,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “predict,” “plan,” “may,” “should,” “will,” “would,” “potential,” “seem,” “seek,” “outlook,” and similar expressions that predict or indicate future events or trends, or that are not statements of historical matters. Forward-looking statements are predictions, projections, and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Forward looking statements included in this press release include statements about AEye’s products, the Company’s progress in commercialization and manufacturing, the potential of new market segments, and the Company’s expected future growth, among others. These statements are based on various assumptions, whether or not identified in this press release. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by an investor as a guarantee, an assurance, a prediction, or a definitive statement of fact or probability. Actual events and circumstances are very difficult or impossible to predict and will differ from the assumptions. Many actual events and circumstances are beyond the control of
Readers are cautioned not to put undue reliance on forward-looking statements;
Condensed Consolidated Balance Sheets (In thousands) (Unaudited) |
|||||||
2022 |
2021 |
||||||
ASSETS | |||||||
Current Assets: | |||||||
Cash and cash equivalents | $ | 58,490 |
|
$ | 14,183 |
|
|
Marketable securities | 53,699 |
|
149,824 |
|
|||
Accounts receivable, net | 624 |
|
4,222 |
|
|||
Inventories, net | 4,024 |
|
4,085 |
|
|||
Prepaid and other current assets | 5,496 |
|
5,051 |
|
|||
Total current assets | 122,333 |
|
177,365 |
|
|||
Right-of-use assets | 15,847 |
|
— |
|
|||
Property and equipment, net | 7,621 |
|
5,129 |
|
|||
Restricted cash | 2,150 |
|
2,150 |
|
|||
Other noncurrent assets | 2,739 |
|
1,509 |
|
|||
Total assets | $ | 150,690 |
|
$ | 186,153 |
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | |||||||
Current Liabilities: | |||||||
Accounts payable | $ | 1,175 |
|
$ | 2,542 |
|
|
Accrued expenses and other current liabilities | 9,888 |
|
8,739 |
|
|||
Contract liabilities | 1,518 |
|
2,287 |
|
|||
Convertible notes | 9,512 |
|
— |
|
|||
Total current liabilities | 22,093 |
|
13,568 |
|
|||
Operating lease liabilities, noncurrent | 17,058 |
|
— |
|
|||
Deferred rent, noncurrent | — |
|
3,032 |
|
|||
Other noncurrent liabilities | 518 |
|
786 |
|
|||
Total liabilities | 39,669 |
|
17,386 |
|
|||
Stockholders’ Equity (Deficit): | |||||||
Preferred stock | — |
|
— |
|
|||
Common stock | 16 |
|
16 |
|
|||
Additional paid-in capital | 339,408 |
|
320,937 |
|
|||
Accumulated other comprehensive loss | (1,636 |
) |
(391 |
) |
|||
Accumulated deficit | (226,767 |
) |
(151,795 |
) |
|||
Total stockholders’ equity (deficit) | 111,021 |
|
168,767 |
|
|||
Total liabilities and stockholders’ equity (deficit) | $ | 150,690 |
|
$ | 186,153 |
|
|
Condensed Consolidated Statements of Operations (In thousands, except share and per share data) (Unaudited) |
|||||||||||||||
Three months ended |
Nine months ended |
||||||||||||||
2022 |
2021 |
2022 |
2021 |
||||||||||||
Revenue: | |||||||||||||||
Prototype sales | $ | 652 |
|
$ | 127 |
|
$ | 1,182 |
|
$ | 588 |
|
|||
Development contracts | 115 |
|
— |
|
1,373 |
|
615 |
|
|||||||
Total revenues | 767 |
|
127 |
|
2,555 |
|
1,203 |
|
|||||||
Cost of revenue | 2,708 |
|
466 |
|
5,617 |
|
1,537 |
|
|||||||
Gross profit (loss) | (1,941 |
) |
(339 |
) |
(3,062 |
) |
(334 |
) |
|||||||
Operating Expenses: | |||||||||||||||
Research and development | 8,971 |
|
7,468 |
|
28,309 |
|
19,030 |
|
|||||||
Sales and marketing | 4,466 |
|
2,991 |
|
14,405 |
|
6,489 |
|
|||||||
General and administrative | 7,896 |
|
6,086 |
|
29,053 |
|
13,846 |
|
|||||||
Total operating expenses | 21,333 |
|
16,545 |
|
71,767 |
|
39,365 |
|
|||||||
Loss from operations | (23,274 |
) |
(16,884 |
) |
(74,829 |
) |
(39,699 |
) |
|||||||
Other income (expense), net: | |||||||||||||||
Change in fair value of embedded derivative liability and warrant liabilities | 16 |
|
341 |
|
125 |
|
222 |
|
|||||||
Gain on PPP loan forgiveness | — |
|
— |
|
— |
|
2,297 |
|
|||||||
Interest income and other | 335 |
|
69 |
|
1,109 |
|
74 |
|
|||||||
Interest expense and other | (688 |
) |
(919 |
) |
(1,338 |
) |
(2,871 |
) |
|||||||
Total other income (expense), net | (337 |
) |
(509 |
) |
(104 |
) |
(278 |
) |
|||||||
Provision for income tax expense | 13 |
|
— |
|
39 |
|
— |
|
|||||||
Net loss | $ | (23,624 |
) |
$ | (17,393 |
) |
$ | (74,972 |
) |
$ | (39,977 |
) |
|||
Per Share Data | |||||||||||||||
Net loss per common share (basic and diluted) | $ | (0.15 |
) |
$ | (0.15 |
) |
$ | (0.48 |
) |
$ | (0.39 |
) |
|||
Weighted average common shares outstanding (basic and diluted) | 159,312,203 |
|
114,891,595 |
|
156,702,000 |
|
102,953,263 |
|
|||||||
Condensed Consolidated Statements of Cash Flows (In thousands) (Unaudited) |
|||||||
Nine Months Ended |
|||||||
2022 |
2021 |
||||||
Cash flows from operating activities: | |||||||
Net loss | $ | (74,972 |
) |
$ | (39,977 |
) |
|
Adjustments to reconcile net loss to net cash used in operating activities: | |||||||
Depreciation and amortization | 794 |
|
769 |
|
|||
Noncash lease expense relating to operating lease right-of-use assets | 993 |
|
— |
|
|||
Inventory write-downs, net of scrapped inventory | 576 |
|
— |
|
|||
Change in fair value of embedded derivative liability and warrant liabilities | (125 |
) |
(222 |
) |
|||
Noncash gain on PPP loan forgiveness | — |
|
(2,297 |
) |
|||
Stock-based compensation | 18,003 |
|
6,522 |
|
|||
Amortization of debt issuance costs | — |
|
725 |
|
|||
Amortization of debt discount | — |
|
752 |
|
|||
Realized loss on redemption of marketable securities | 77 |
|
— |
|
|||
Amortization of premiums on marketable securities, net of change in accrued interest | 1,211 |
|
47 |
|
|||
Other | — |
|
286 |
|
|||
Changes in operating assets and liabilities: | |||||||
Accounts receivable, net | 3,598 |
|
9 |
|
|||
Inventories, current and noncurrent, net | (2,256 |
) |
(2,197 |
) |
|||
Prepaid and other current assets | (445 |
) |
(5,305 |
) |
|||
Other noncurrent assets | 420 |
|
(142 |
) |
|||
Accounts payable | (1,236 |
) |
840 |
|
|||
Accrued expenses and other current liabilities | 220 |
|
1,417 |
|
|||
Operating lease liabilities | (983 |
) |
— |
|
|||
Deferred rent | — |
|
(400 |
) |
|||
Contract liabilities | (1,400 |
) |
(415 |
) |
|||
Net cash used in operating activities | (55,525 |
) |
(39,588 |
) |
|||
Cash flows from investing activities: | |||||||
Purchase of property and equipment | (3,402 |
) |
(713 |
) |
|||
Proceeds from redemptions and maturities of marketable securities | 93,592 |
|
— |
|
|||
Purchase of available-for-sale securities | — |
|
(129,999 |
) |
|||
Net cash provided by (used in) operating activities | 90,190 |
|
(130,712 |
) |
|||
Cash flows from financing activities: | |||||||
Proceeds from exercise of stock options | 1,032 |
|
100 |
|
|||
Proceeds from Business Combination and PIPE financing | — |
|
256,811 |
|
|||
Transaction costs related to Business Combination and PIPE financing | — |
|
(50,985 |
) |
|||
Proceeds from the issuance of convertible notes | 10,000 |
|
8,045 |
|
|||
Proceeds from bank loan | — |
|
10,000 |
|
|||
Principal payments on bank loans | — |
|
(13,333 |
) |
|||
Payment of debt issuance costs | — |
|
(717 |
) |
|||
Taxes paid related to the net share settlement of equity awards | (4,252 |
) |
— |
|
|||
Repurchase of stock options | — |
|
(1,500 |
) |
|||
Proceeds from issuance of common stock under the Common Stock Purchase Agreement | 2,891 |
|
— |
|
|||
Stock issuance costs related to the Common Stock Purchase Agreement | (29 |
) |
— |
|
|||
Net cash provided by financing activities | 9,642 |
|
208,421 |
|
|||
Net increase in cash, cash equivalents and restricted cash | 44,307 |
|
38,121 |
|
|||
Cash, cash equivalents and restricted cash at beginning of period | 16,333 |
|
16,497 |
|
|||
Cash, cash equivalents and restricted cash at end of period | $ |
60,640 |
|
$ |
54,618 |
|
|
Reconciliation of GAAP to Non-GAAP Financial Measures (In thousands, except share and per share data) (Unaudited) |
|||||||||||||||
Three months ended |
Nine months ended |
||||||||||||||
2022 |
2021 |
2022 |
2021 |
||||||||||||
GAAP net loss | $ | (23,624 |
) |
$ | (17,393 |
) |
$ | (74,972 |
) |
$ | (39,977 |
) |
|||
Non-GAAP adjustments: | |||||||||||||||
Stock-based compensation | 6,106 |
|
2,292 |
|
18,003 |
|
6,522 |
|
|||||||
Expenses related to registration statement on Form S-1/S-3s | 54 |
|
1,773 |
|
304 |
|
2,198 |
|
|||||||
Change in fair value of embedded derivative and warrant liabilities | (16 |
) |
(341 |
) |
(125 |
) |
(222 |
) |
|||||||
Stock issuance costs | — |
|
— |
|
28 |
|
— |
|
|||||||
Debt issuance costs | 437 |
|
— |
|
437 |
|
— |
|
|||||||
Gain on PPP Loan Forgiveness | — |
|
— |
|
— |
|
(2,297 |
) |
|||||||
Non-GAAP net loss | $ | (17,043 |
) |
$ | (13,669 |
) |
$ | (56,325 |
) |
$ | (33,776 |
) |
|||
Depreciation and amortization expense | 331 |
|
271 |
|
794 |
|
769 |
|
|||||||
Interest income and other | (335 |
) |
(69 |
) |
(1,109 |
) |
(74 |
) |
|||||||
Interest expense and other | 307 |
|
919 |
|
928 |
|
2,871 |
|
|||||||
Provision for income tax expense | 13 |
|
— |
|
39 |
|
— |
|
|||||||
Adjusted EBITDA | $ | (16,727 |
) |
$ | (12,548 |
) |
$ | (55,673 |
) |
$ | (30,210 |
) |
|||
GAAP net loss per share attributable to common stockholders: | |||||||||||||||
Basic and diluted | $ | (0.15 |
) |
$ | (0.15 |
) |
$ | (0.48 |
) |
$ | (0.39 |
) |
|||
Non-GAAP net loss per share attributable to common stockholders: | |||||||||||||||
Basic and diluted | $ | (0.11 |
) |
$ | (0.12 |
) |
$ | (0.36 |
) |
$ | (0.33 |
) |
|||
Shares used in computing GAAP net loss per share attributable to common stockholders: | |||||||||||||||
Basic and diluted | 159,312,203 |
|
114,891,595 |
|
156,702,000 |
|
102,953,263 |
|
|||||||
Shares used in computing Non-GAAP net loss per share attributable to common stockholders: | |||||||||||||||
Basic and diluted | 159,312,203 |
|
114,891,595 |
|
156,702,000 |
|
102,953,263 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20221110005446/en/
Media:
jennifer@aeye.ai
925-400-4366
AEye@landispr.com
415-717-9133
Investors:
cmontevirgen@aeye.ai
925-400-4366
AEye@lambert.com
212-971-9718
Source:
FAQ
What were AEye's revenue and net loss for Q3 2022?
What is the significance of the 4Sight™ product line launched by AEye?
What partnerships did AEye announce in their press release?
How much cash and cash equivalents did AEye have as of September 30, 2022?